PREC.
SUIV.
When should immunotherapy be stopped in
responders?
Celine Mascaux, MD, PhD
Celine Mascaux, MD, PhD
Celine.mascaux@chru-Strasbourg.fr
Celine.mascaux@chru-Strasbourg.fr
IFODS, 22 June 2022
00000000
00000000
00000000
00000000